$547.80
▲ +0.3% Today
as of Sep 4, 16:56 ET
Last 30 days
Recent Press Releases & News
lean bull
▲ 5
● 20
▼ 0
Vertex vs. Regeneron: Which Biotech Giant Is the Better Buy Right Now?
How Is Vertex Pharmaceuticals' Stock Performance Compared to Other Biotech Stocks?
Why Is Vertex (VRTX) Up 14.4% Since Last Earnings Report?
Overview
52-week range
$374
$560
93% of range
Avg surprise (last 3)
+3.4%
Avg reaction (last 2)
+0.6%
50% positive
Latest IV / EM
44%
EM ±1.8% · $558 · Sep 4
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $4.31 | — | — | — | — | financials |
| Mon May 4, 2026 | Mar/2026 | $3.95 | $3.69 | +7.0% | +11.3% | +1.4% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $4.20 | — | — | — | — | financials |
| Mon Aug 4, 2025 | Jun/2025 | $4.00 | $3.74 | +7.0% | — | — | earnings |
| Mon May 5, 2025 | Mar/2025 | $3.55 | $3.69 | -3.8% | — | -0.2% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $4.01 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-13.92 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $4.21 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $3.97 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $3.52 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $2.69 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.33B | $2.99B | — | $3.08B | $2.96B | $2.77B | — | $2.77B |
| Cost of revenue | $489M | $393M | — | $415M | $408M | $363M | — | $393M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $1.25B | $1.14B | — | $1.19B | $1.15B | $630M | — | $1.12B |
| Net income | $1.10B | $1.03B | — | $1.08B | $1.03B | $646M | — | $1.05B |
| EPS (diluted) | $4.31 | $4.02 | — | $4.20 | $3.99 | $2.49 | — | $4.01 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $6.14B | $5.49B | $5.08B | $4.94B | $4.97B | $4.67B | $4.57B | $5.24B |
| Inventory | $1.77B | $1.77B | $1.69B | $1.63B | $1.50B | $1.36B | $1.21B | $1.08B |
| Total current assets | $12.54B | $11.73B | $11.20B | $10.57B | $10.43B | $10.01B | $9.60B | $9.80B |
| Total assets | $27.42B | $26.48B | $25.64B | $24.86B | $24.04B | $22.88B | $22.53B | $22.24B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $7.18B | $7.12B | $6.98B | $7.54B | $6.86B | $6.38B | $6.12B | $6.61B |
| Total equity | $20.25B | $19.36B | $18.67B | $17.32B | $17.18B | $16.50B | $16.41B | $15.63B |